Member access

4-Traders Homepage  >  Shares  >  Mercado Continuo Espanol  >  FAES Farma SA    FAE   ES0134950F36

FAES FARMA SA (FAE)

5
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
02/20/2015 02/23/2015 02/24/2015 02/25/2015 02/26/2015 Date
2.085(c) 2.085(c) 2.085(c) 2.095(c) 2.095(c) Last
455 770 365 935 416 167 316 517 340 420 Volume
+0.97% 0.00% 0.00% +0.48% 0.00% Change
More quotes
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
07/31Earnings Release
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 193 M
EBIT 2014 31,1 M
Net income 2014 25,5 M
Debt 2014 10,1 M
Yield 2014 2,70%
Sales 2015 204 M
EBIT 2015 36,6 M
Net income 2015 28,8 M
Finance 2015 8,31 M
Yield 2015 2,89%
PER 2014 19,84
PER 2015 16,92
EV / Sales 2014 2,69x
EV / Sales 2015 2,45x
Capitalization 509 M
More Financials
Latest news on FAES FARMA SA
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2013 FAES FARMA SA : Statement 07/24/2013 (24 k.). January-June results.
2012 FAES FARMA SA : Statement 13/12/2012 (20 k). Faes Farma licences bilastine for S..
2012 FAES FARMA SA : Statement 02/07/2012 (19 k). FAES FARMA S.A. informs of the appr..
2012 FAES FARMA SA : ex-dividend day for final dividend
2012 FAES FARMA SA : Statement 26/04/2012 (28 k). FAES FARMA and INVIDA (MENARINI Gro..
2012 FAES FARMA SA : Statement 24/01/2012 (19 k). Bilastine's launch in Brazil.
More news
Sector news Pharmaceuticals - NEC
06:31a ALEXION PHARMACEUTICALS : Joins Patient Organizations Worldwide in Support of In..
05:23a ASTRAZENECA : To Spin-out Early Stage Anti-Infectives R&D Company
03:21a AstraZeneca to carve out antibiotic R&D into separate firm
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF